BioCeramic Therapeutics Ltd. receives first financing round

bioceramictherapeutics_1.jpg

BioCeramic Therapeutics Ltd, a spin-out company from Imperial College co-founded by Dr Molly Stevens and Professor Robert Hill, receives its first financing round.

This funding will enable the company to press forward with its plans to develop a range of bioceramic and nanostructured scaffold products, designed to help patients suffering from musculoskeletal conditions.

Previous
Previous

First woman to win Royal Pharmaceutical Society Science Medal

Next
Next

EPSRC ‘Challenging Engineering’ Award